 |
|
|
| |
HIV-1 Attachment Inhibitor Prodrug in Antiretroviral-Experienced Subjects: Week 24 Analysis
|
| |
| |
AI438011: A Phase IIb, Randomized, Controlled, Partially-Blinded Trial to Investigate the Safety, Efficacy and Dose-response of BMS-663068 in Treatment-Experienced HIV-1-positive Subjects
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
Lalezari J, Latiff GH, Brinson C, Echevarria J, Trevino-Perez S, Bogner JR, Stock D, Joshi SR, Hanna GJ, Lataillade M, for the AI438011 study team
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
|
| |
|
|
|
|
|
